THE CLINICAL TRIAL TO STUDY THE EFFECT OF THE DRUG MANOKARA CHOORANAM IN MALES HAVING INFERTILITY

AN EVALUATION OF MANOKARA CHOORANAM FOR AAN MALADU (MALE INFERTILITY)- AN OPEN CLINICAL STUDY

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/12/016575

Enrollment

Registered

2018-12-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N469- Male infertility, unspecified

Interventions

Intervention1: MANOKARA CHOORANAM: MANOKARA CHOORANAM IS ADMINISTARTTED ORALLY AT THE DOSE OF 1gm TWICE A DAY ALONG WITH MILK AS A ADJUVENT FOR 48 DAYS Control Intervention1: NOT APPLICABLE: NIL

Eligibility

Inclusion criteria

Inclusion criteria: OLIGOSPERMIA (LOW VOLUME OF SEMEN) OLIGOASTHENOSPERMIA (LOW SPERM COUNT WITH LESS THAN 20 MILLIONS) ASTHENOZOOSPERMIA(REDUCED SPERM MOTILITY)

Exclusion criteria

Exclusion criteria: AZOOSPERMIA TERATOSPERMIA HYDROCELE VARICOCELE ERACTILE DYSFUNCTION DIABETES MELLITUS HYPERTENSION CARDIAC DISEASE CANCER ANTI SPERM ANTIBODY

Design outcomes

Primary

Measure	Time frame
OUTCOME IS MAINLY ASSESSED BY INCREASED SPERM COUNT AND IMPROVED MOTILITY BY 20 PERCENTAGE .THIS WILL BE CONSIDERED AS SUCCESSFULL MEASURESTimepoint: OUTCOME IS MAINLY ASSESSED BY INCREASED SPERM COUNT AND IMPROVED MOTILITY BY 20 PERCENTAGE .THIS WILL BE CONSIDERED AS SUCCESSFULL MEASURES	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDR RAMACHANDRAN P

GOVERNMENT SIDDHA MEDICAL COLLEGE ARUMBAKKAM CHENNAI

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026